CHIRON |
Science
For Life
TRAFFIC Summary 1
A single intra-arterial infusion of rFGF-2 improves peak
walking time at 90 days (pairwise p=0.026 vs
placebo)
Prespecified 3-way ANOVA p=0.075
3-way ANOVA of Ranks p=0.035
3-way ANOVA of Ranks p=0.035
TRAFFIC was powered for DOUBLE being superior to SINGLE. Therefore, it was underpowered to detect a
60s benefit in both treatment
groups.
Repeat infusion at 30 days is not better than single